Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
Phathom Pharmaceuticals will report third quarter 2026 financial results and provide a business update via live webcast at 8:00 am EDT on Thursday, October 29, 2026. The release is a scheduling notice only, containing no financial figures or new business developments. Phathom markets vonoprazan (VOQUEZNA) in the U.S. for GERD and H.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.